Latest Breaking News On - Therapy candidate - Page 1 : comparemela.com

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Milos miljkovicDavid rosenMelissa forstCartesian therapeutics incDrug administrationExchange commissionTherapy candidateMonth follow upLancet neurologyChief medical officerDaily livingOrphan drug designationInvestigational new drugPrivate securities litigation reform actAnnual reportQuarterly reports

StreetInsider com - Corporate News

StreetInsider com - Corporate News
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jackl wyszomierskiAmlexicon pharmaAmbread financial holdingsAmus district court issues decisionNames owen hughesChief executive officerAppoints jackBoard issues open letterFinancial holdingsPrivate notesSales resultsQuarter to date through januaryProvides businessPipeline updateCourt issues decisionAnnounces positive long term follow up data

Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual Meeting

- First Preclinical Data Sets Demonstrating Potential to Re-Dose with AAVHSCs and to Identify Genomic Sites with Improved Gene Editing Integration Efficiency - BEDFORD, Mass., May 03, 2023 . | May 3, 2023

Oxford biomedicaAlbert seymourCara mayfieldBrad smithAmerican society of gene cell therapyExchange commissionGlobenewswire incSecurities exchangeCompany contactsHomology medicines incCorporate communicationsIdentify genomic sitesImproved gene editing integration efficiencyCell therapyAnnual meetingChief executive officer

Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Society s 2022 Scientific Sessions

Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Society s 2022 Scientific Sessions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWhit tingleyMilind desaiMediawendy ryantenBridge communicationsDrug administrationTenaya therapeutics incHypertrophic cardiomyopathy medical societyUniversity of texas southwestern medical centerNational harborVascular thoracic institute at cleveland clinicWall streetHypertrophic cardiomyopathyClinical operationsThoracic instituteCleveland clinic

Imugene Limited upgraded to Buy and target price boosted to 52 cents by Bell Porter on back of capital raise and new HER vaxx trials

Imugene Limited upgraded to Buy and target price boosted to 52 cents by Bell Porter on back of capital raise and new HER vaxx trials
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Axicabtagene ciloleucelBell porterKite pharmaTherapy candidatePriority reviewExpedited review